Research News
OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape…
OCRA-Funded Research Advances Immunotherapy
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr…
OCRA-Funded Research Breakthroughs in 2019
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives…
OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer
(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community…
OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide…
IUD May Lower Risk of Developing Ovarian Cancer
(November 6, 2019) A recent research review conducted by a team at the University of Colorado Anschutz, and published this month by the American College of Obstetrics and Gynecology, found that use of an intrauterine device (IUD) was associated with…
OCRA-Funded Research Explores New Pathways for Understanding Metastases
(October 30) In an effort to further understand disease initiation and progression, OCRA grantee Dr…
PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival
(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr…
OCRA-Funded Research Elucidates New Immunotherapy Approach
(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach…
OCRA-Funded Research Points to Surrounding Tissues for Further Study
(September 10, 2019) Ovarian clear-cell carcinoma is an aggressive form of ovarian cancer. Endometriosis is derived from the uterine endometrium and is a known risk factor for ovarian clear-cell carcinoma…
OCRA-Funded Research Moves Immunotherapy Forward
(September 5, 2019) OCRA funded investigator Dmitriy Zamarin, MD, PhD contributed to a study that provides an intriguing hypothesis that mutation in genes like SMARCA4 may improve tumor recognition by the immune system…
Should You Be Tested for BRCA Mutations? New Guidelines
(August 22, 2019) This week, The US Preventive Services Task Force published new recommendations on risk assessment, genetic counseling, and genetic testing for BRCA mutations and BRCA-related cancers…